ID: ALA3091611

Max Phase: Preclinical

Molecular Formula: C16H15NO4

Molecular Weight: 285.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)c1c(O)c(C)nc(Cc2ccccc2)c1C(=O)O

Standard InChI:  InChI=1S/C16H15NO4/c1-9-15(19)13(10(2)18)14(16(20)21)12(17-9)8-11-6-4-3-5-7-11/h3-7,19H,8H2,1-2H3,(H,20,21)

Standard InChI Key:  RVQGFISZZZDMCD-UHFFFAOYSA-N

Associated Targets(Human)

P2X purinoceptor 7 5534 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P2X purinoceptor 3 1991 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2X purinoceptor 1 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 285.30Molecular Weight (Monoisotopic): 285.1001AlogP: 2.59#Rotatable Bonds: 4
Polar Surface Area: 87.49Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.49CX Basic pKa: 2.79CX LogP: 2.21CX LogD: -0.46
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.84Np Likeness Score: 0.02

References

1. Cho JH, Jung KY, Jung Y, Kim MH, Ko H, Park CS, Kim YC..  (2013)  Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.,  70  [PMID:24246730] [10.1016/j.ejmech.2013.10.026]

Source